SailPoint's IPO aims to raise funds for debt repayment, equity settlements, advisory fees and general corporate purposes, ...

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and a plan to develop drugs for brain function and health.

The Austin, Texas-based company and its parent Thoma Bravo sold 60 million shares at $23 apiece, giving SailPoint a valuation ...

SailPoint first went public in 2017, three years after being acquired by private equity firm Thoma Bravo, which bought it ...

("SailPoint"), a leader in unified identity security for enterprises, today announced the pricing of its upsized initial public offering of 60,000,000 shares of its common stock at a public offering ...

Goldman Sachs will no longer bar companies with all White boards from receiving IPO services as business after business drops ...

A growing number of prominent companies have scaled back or set aside the diversity, equity and inclusion initiatives that ...

Cryptocurrency custody firm BitGo is the latest digital asset firm to announce plans to hold an initial public offering (IPO) this ...

Goldman Sachs has ended a ban on underwriting companies with all-White, all-male boards, becoming the latest corporate giant ...

In 2020, Goldman Sachs made a big splash by declaring the bank would refuse to take a company public if the business didn't ...

Goldman Sachs will drop a demand that corporate boards of directors include women and members of minority groups as financial ...

Goldman Sachs cancelled a four-year-old policy to only take public companies that had two diverse board members, a ...